Investor Relations
FY2021 Q1 Financial Results posted
2021-07-30
contributes to the enrichment
of human life
through leading-edge technology
“increase in eye disease resulting from global population aging” “concerns for food shortages resulting
from global population growth” “shortage of skilled engineers resulting from globally rising infrastructure demands.”
Topcon is promoting its efforts to solve societal challenges of “healthcare” “agriculture”
and “infrastructure” utilizing DX solutions.
Eye Care
Topcon acquires VISIA Imaging S.r.l, ophthalmic medical device manufacturer in Italy
2021-07-07
Investor Relations
Notice of change (additional appointment) of Representative Director
2021-06-25
Smart Infrastructure
Establishment of "TOPCON POSITIONING ASIA (MALAYSIA) SDN. BHD"
2021-06-25
Other
Response to COVID-19 (Updated May 31)
2021-05-31
Investor Relations
The 128th Ordinary General Meeting of Shareholders
2021-05-28
Investor Relations
Notice of amendment to the Articles of Incorporation and change (resignation) of Representative Director (Makoto Iwasaki)
2021-05-25
Investor Relations
Notice regarding dividend of surplus
2021-05-25
Other
Response to COVID-19 (Updated May 11)
2021-05-11
About Topcon
Established in 1932 and currently a global company with 80% of sales and 70% of employees from overseas.
Introducing Topcon’s policy, outline and history.
Investor Relations
Introducing Topcon’s efforts toward continuous growth and improvement of mid- and long-term corporate values.
While life has become convenient by the development of society and industry, our community carries various issues.
Topcon will continue to contribute to an even more rich and sustainable society in familiar areas of “healthcare” “agriculture” and “infrastructure”, the foundations of human life.
News & Topics
- News Release
- Topics